Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Lifevantage Corp

NASDAQ: LFVN · Life Sciences · 5 alerts · CIK 849146

Share price
$4.77Close, Nov 16
Market cap
$59.8M
Shares outstanding
12.53MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Lifevantage Corp filings on SEC EDGAR ↗

4:09 PM ET Form 4
Insider Selling

Lifevantage Director Michael A. Beindorff Sells $48.9K of Stock

Michael A. Beindorff, Director, sold 10,000 shares of Lifevantage Corp at $4.89 a share, worth $48.9K in total on Nov 12, 2026. Shares held after the trade: 31,625 (-24.0%).

Value
$48.9K
Shares
10,000
Price
$4.89
Role
Director
Holding change
-24.0%
Trade date
Nov 12, 2026
4:06 PM ET 8-K
Shareholder Meeting

Lifevantage Shareholder Meeting

LifeVantage Corporation held its fiscal year 2027 annual meeting of stockholders on November 5, 2026. Shareholders elected six directors to the board, approved executive compensation on an advisory basis, and ratified Deloitte & Touche, LLP as the independent accounting firm for the fiscal year ending June 30, 2027.

4:07 PM ET 8-K
Financial Results

Lifevantage Financial Results

LifeVantage Corp reported financial results for the first quarter of fiscal 2027, with revenue declining 22% to $37.1 million due to lower active accounts and GLP-1 system sales. The company reported a net loss of $0.02 per diluted share and is implementing a new strategy to transform into a brand-driven, consumer-focused company with a more efficient operating model.

Term
Q1 2027

“Despite a challenging quarter, LifeVantage has significant untapped potential, and we now have a clear strategy designed to capture it. Our focus is on transforming LifeVantage into a more brand-driven, consumer-focused company, supported by a modern digital platform and an expanding community of consumers and brand advocates.”

Terrence Moorehead, President and Chief Executive Officer
4:11 PM ET 8-K
Other 8-K Filing

Lifevantage Other 8-K Filing

LifeVantage Corporation has changed its fiscal year end from June 30 to December 31 to align with the calendar year. The company will file a transition report on Form 10-KT for the period from July 1, 2026, to December 31, 2026.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.